BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ·Healthcare·Biotechnology
$8.72
+2.53%
Mkt Cap $1.72B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (12 analysts)
$17.00
Range $9.00 – $25.00
Implied Upside
+95.1%
Consensus $17.00 vs current $8.72
NASDAQ·Healthcare·Biotechnology
$8.72
+2.53%
Mkt Cap $1.72B
Buy
4
Hold
0
Sell
0
Price Target (12 analysts)
$17.00
Range $9.00 – $25.00
+95.1%
Consensus $17.00 vs current $8.72